Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-1041

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters ; day:14 ; month:7 ; year:2020 ; pages:1-7
European journal of clinical pharmacology ; (14.7.2020), 1-7

Creator: Katsube, Takayuki
Inoue, Yuji
Fukuhara, Takahiro
Kano, Takeshi
Wajima, Toshihiro

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00228-020-02960-7

URN: urn:nbn:de:101:1-2020091020111730549309

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Katsube, Takayuki
Inoue, Yuji
Fukuhara, Takahiro
Kano, Takeshi
Wajima, Toshihiro
SpringerLink (Online service)

Other Objects (12)

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

DPDDI: a deep predictor for drug-drug interactions

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Related objects

Reset password